These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 2837500
1. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity. Miyauchi A, Fukase M, Tsutsumi M, Fujita T. J Clin Endocrinol Metab; 1988 Jul; 67(1):46-53. PubMed ID: 2837500 [Abstract] [Full Text] [Related]
2. Tumor-induced osteomalacia: clinical and basic studies. Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL. J Bone Miner Res; 1997 Sep; 12(9):1502-11. PubMed ID: 9286768 [Abstract] [Full Text] [Related]
3. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T. Proc Natl Acad Sci U S A; 2001 May 22; 98(11):6500-5. PubMed ID: 11344269 [Abstract] [Full Text] [Related]
4. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report. Tartaglia F, Minisola S, Sgueglia M, Blasi S, Brunelli D, Degli Effetti E, Maturo A, Cola A, Custureri F, Campana FP. G Chir; 2006 May 22; 27(1-2):9-13. PubMed ID: 16608626 [Abstract] [Full Text] [Related]
5. [Oncogenic osteomalacia: its pathogenesis, clinical picture and treatment]. Ermolenko VM, Melikaian AM, Shotemor ShSh, Potapova AV. Ter Arkh; 1995 May 22; 67(5):58-61. PubMed ID: 7638783 [Abstract] [Full Text] [Related]
6. Investigation of the mechanism for abnormal renal 25-hydroxyvitamin D3-1-hydroxylase activity in the X-linked Hyp mouse. Tenenhouse HS. Endocrinology; 1984 Aug 22; 115(2):634-9. PubMed ID: 6086274 [Abstract] [Full Text] [Related]
7. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. Drezner MK, Lyles KW, Haussler MR, Harrelson JM. J Clin Invest; 1980 Nov 22; 66(5):1020-32. PubMed ID: 6253520 [Abstract] [Full Text] [Related]
8. Variable phosphate-mediated regulation of vitamin D metabolism in the murine hypophosphatemic rachitic/osteomalacic disorders. Davidai GA, Nesbitt T, Drezner MK. Endocrinology; 1991 Mar 22; 128(3):1270-6. PubMed ID: 1999147 [Abstract] [Full Text] [Related]
9. Case of the winter season. Hypophosphatemic osteomalacia secondary to hemangiopericytoma of the right femur. Robertson A. Semin Roentgenol; 1983 Jan 22; 18(1):5-6. PubMed ID: 6836336 [No Abstract] [Full Text] [Related]
10. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, Jan De Beur SM, Schiavi SC, Kumar R. J Clin Invest; 2003 Sep 22; 112(5):785-94. PubMed ID: 12952927 [Abstract] [Full Text] [Related]
11. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. Sato K, Nohtomi K, Demura H, Takeuchi A, Kobayashi T, Kazama J, Ozawa H. Bone; 1997 Jul 22; 21(1):57-64. PubMed ID: 9213008 [Abstract] [Full Text] [Related]
12. Abnormal adenosine 3'.5'-monophosphate stimulation of renal 1,25-dihydroxyvitamin D production in hyp mice: evidence that 25-hydroxyvitamin D-1 alpha-hydroxylase dysfunction results from aberrant intracellular function. Nesbitt T, Davidai GA, Drezner MK. Endocrinology; 1989 Mar 22; 124(3):1184-9. PubMed ID: 2537175 [Abstract] [Full Text] [Related]
13. Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism. Nesbitt T, Drezner MK, Lobaugh B. J Clin Invest; 1986 Jan 22; 77(1):181-7. PubMed ID: 3753708 [Abstract] [Full Text] [Related]
14. Adult-onset hypophosphatemic osteomalacia secondary to neoplasm. A case report and review of the pathophysiology. Gitelis S, Ryan WG, Rosenberg AG, Templeton AC. J Bone Joint Surg Am; 1986 Jan 22; 68(1):134-8. PubMed ID: 3941116 [No Abstract] [Full Text] [Related]
15. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity. Lyles KW, Drezner MK. J Clin Endocrinol Metab; 1982 Mar 22; 54(3):638-44. PubMed ID: 6276432 [Abstract] [Full Text] [Related]
16. [Oncogenic hypophosphatemic osteomalacia]. Schultze G, Delling G, Faensen M, Haubold R, Loy V, Molzahn M, Pommer W, Semler J, Trempenau B. Dtsch Med Wochenschr; 1989 Jul 07; 114(27):1073-8. PubMed ID: 2737097 [Abstract] [Full Text] [Related]
18. Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis. Mizuno Y, Masaki N, Hashimoto H, Ogata I, Aizawa C, Fujiwara K, Toda G, Mori M, Machinami R, Kurokawa K. Jpn J Med; 1991 Mar 07; 30(1):81-6. PubMed ID: 1713978 [Abstract] [Full Text] [Related]
19. Oncogenic osteomalacia: two case reports with surprisingly different outcomes. Seijas R, Ares O, Sierra J, Pérez-Dominguez M. Arch Orthop Trauma Surg; 2009 Apr 07; 129(4):533-9. PubMed ID: 19125258 [Abstract] [Full Text] [Related]
20. Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone. Drezner MK, Feinglos MN. J Clin Invest; 1977 Nov 07; 60(5):1046-53. PubMed ID: 908749 [Abstract] [Full Text] [Related] Page: [Next] [New Search]